Pathway | Positive | Measured | Z score | p value | Cancer/general |
---|---|---|---|---|---|
Retinoblastoma (RB) in cancer | 35 | 87 | 12.63 | 0.001 | Cancer |
DNA replication | 22 | 42 | 11.91 | 0.001 | General |
Cell cycle | 34 | 100 | 11.04 | 0.001 | General |
Gastric cancer network 1 | 15 | 26 | 10.44 | 0.001 | Cancer |
Histone modifications | 25 | 64 | 10.44 | 0.001 | General |
G1-to-S cell cycle control | 23 | 67 | 9.12 | 0.001 | General |
DNA damage response | 15 | 64 | 5.4 | 0.001 | General |
Gastric cancer network 2 | 9 | 30 | 5.13 | 0.001 | Cancer |
ATM signalling pathway | 10 | 38 | 4.87 | 0.001 | General |
Fluoropyrimidine activity | 8 | 32 | 4.16 | 0.001 | General |
Integrated pancreatic cancer pathway | 27 | 195 | 4.08 | 0.001 | Cancer |
Integrated cancer pathway | 8 | 35 | 3.85 | 0.005 | Cancer |
Integrated breast cancer pathway | 21 | 157 | 3.41 | 0.002 | Cancer |
Arylhydrocarbon receptor (AhR) signalling pathway | 5 | 27 | 2.47 | 0.015 | General |
Signalling pathways in glioblastoma | 10 | 82 | 2.02 | 0.048 | Cancer |